STATE OF WISCONSIN INVESTMENT BOARD - NGM BIOPHARMACEUTICALS INC ownership

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 89 filers reported holding NGM BIOPHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 2.6%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$125,939
-70.6%
117,700
-29.0%
0.00%
-100.0%
Q2 2023$429,080
-27.2%
165,668
+14.6%
0.00%
-50.0%
Q1 2023$589,654
-23.3%
144,523
-5.7%
0.00%0.0%
Q4 2022$769,154
+89.9%
153,218
+394.5%
0.00%
+100.0%
Q3 2022$405,000
-2.4%
30,983
-4.3%
0.00%0.0%
Q2 2022$415,000
-18.8%
32,360
-3.4%
0.00%0.0%
Q1 2022$511,000
-13.8%
33,5000.0%0.00%0.0%
Q4 2021$593,000
-15.8%
33,5000.0%0.00%0.0%
Q3 2021$704,000
+6.5%
33,5000.0%0.00%0.0%
Q2 2021$661,000
-32.1%
33,5000.0%0.00%
-50.0%
Q1 2021$974,000
-4.0%
33,5000.0%0.00%0.0%
Q4 2020$1,015,000
+69.2%
33,500
-11.1%
0.00%
+100.0%
Q3 2020$600,000
-19.4%
37,7000.0%0.00%
-50.0%
Q2 2020$744,000
+60.0%
37,7000.0%0.00%0.0%
Q1 2020$465,000
+148.7%
37,700
+273.3%
0.00%
Q4 2019$187,000
+33.6%
10,1000.0%0.00%
Q3 2019$140,00010,1000.00%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Column Group LLC 18,136,735$237,228,00052.50%
Ponoi II Management, LLC 1,298,908$16,990,00044.41%
Ponoi Management, LLC 1,298,908$16,990,00023.20%
Euclidean Capital LLC 746,674$9,766,0009.07%
StepStone Group LP 1,573,357$20,580,0002.93%
Logos Global Management LP 850,000$11,118,0001.37%
First Light Asset Management, LLC 955,505$12,498,0001.26%
GREAT POINT PARTNERS LLC 316,256$4,137,0001.00%
Rubric Capital Management LP 877,161$11,473,0000.58%
Avidity Partners Management LP 1,798,100$23,519,0000.48%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders